Literature DB >> 15605985

Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats.

Katharina Maier1, Christian R Rau, Maria K Storch, Muriel B Sättler, Iris Demmer, Robert Weissert, Naimeh Taheri, Antje V Kuhnert, Mathias Bähr, Ricarda Diem.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS which leads to demyelination, axonal destruction and neuronal loss in the early stages. Available therapies mainly target the inflammatory component of the disease but fail to prevent neurodegeneration. To investigate the effect of ciliary neurotrophic factor (CNTF) on the survival of retinal ganglion cells (RGCs), the neurons that form the axons of the optic nerve, we used a rat model of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Optic neuritis in this model was diagnosed by recording visual evoked potentials, and RGC function was monitored by measuring electroretinograms. This study demonstrates that CNTF has a neuroprotective effect on affected RGCs during acute optic neuritis. Furthermore, we demonstrate that CNTF exerts its neuroprotective effect through activation of the Janus kinase/signal transducer and activator of transcription pathway, mitogen activated protein kinases and a shift in the Bcl-2 family of proteins towards the anti-apoptotic side. In summary, our results demonstrate that CNTF can serve as an effective neuroprotective treatment in a rat model of MS that especially reflects the neurodegenerative aspects of this disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15605985     DOI: 10.1111/j.1750-3639.2004.tb00081.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  18 in total

1.  Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.

Authors:  Tanja Kuhlmann; Leah Remington; Isabelle Cognet; Lyne Bourbonniere; Simone Zehntner; Florence Guilhot; Alexandra Herman; Angélique Guay-Giroux; Jack P Antel; Trevor Owens; Jean-François Gauchat
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 2.  The role of growth factors as a therapeutic approach to demyelinating disease.

Authors:  Yangyang Huang; Cheryl F Dreyfus
Journal:  Exp Neurol       Date:  2016-03-22       Impact factor: 5.330

3.  Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa.

Authors:  Kun Do Rhee; Alberto Ruiz; Jacque L Duncan; William W Hauswirth; Matthew M Lavail; Dean Bok; Xian-Jie Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

4.  Anti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritis.

Authors:  Christian R Rau; Katharina Hein; Muriel B Sättler; Benedikt Kretzschmar; Carina Hillgruber; Bradford L McRae; Ricarda Diem; Mathias Bähr
Journal:  Am J Pathol       Date:  2011-02-26       Impact factor: 4.307

5.  Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study.

Authors:  Katharina Maier; Antje V Kuhnert; Naimeh Taheri; Muriel B Sättler; Maria K Storch; Sarah K Williams; Mathias Bähr; Ricarda Diem
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Ciliary neurotrophic factor role in myelin oligodendrocyte glycoprotein expression in Cuprizone-induced multiple sclerosis mice.

Authors:  Zivar Salehi; Sara Pishgah Hadiyan; Reza Navidi
Journal:  Cell Mol Neurobiol       Date:  2013-02-27       Impact factor: 5.046

7.  Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.

Authors:  Arabinda Das; M Kelly Guyton; Amena Smith; Gerald Wallace; Misty L McDowell; Denise D Matzelle; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2012-11-22       Impact factor: 5.372

8.  Apoptotic mechanisms within the retina in Staphylococcus epidermidis experimental endophthalmitis.

Authors:  Nikolaos M Pharmakakis; Ioannis K Petropoulos; Constantine D Georgakopoulos; Chrysoula V Vantzou; Evangelos D Anastassiou; Anestis Mavropoulos; Vassiliki Zolota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-28       Impact factor: 3.117

9.  Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.

Authors:  Muriel B Sättler; Sarah K Williams; Clemens Neusch; Markus Otto; Jens R Pehlke; Mathias Bähr; Ricarda Diem
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

10.  AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model.

Authors:  Ajaib S Paintlia; Manjeet K Paintlia; Sarumathi Mohan; Avtar K Singh; Inderjit Singh
Journal:  Am J Pathol       Date:  2013-06-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.